Know Cancer

or
forgot password

A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Hepatocellular Carcinoma


N/A
18 Years
N/A
Open (Enrolling)
Both
Carcinoma, Hepatocellular

Thank you

Trial Information

A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Hepatocellular Carcinoma


Inclusion Criteria:



- Confirmed hepatocellular carcinoma not suitable for surgery

Exclusion Criteria:

- Portal vein thrombosis

- Severe arteriovenous shunt

- Bilirubin level > 50 umol/mL

- Prothrombin time > 5 seconds

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

regression of tumour size

Outcome Time Frame:

assessment every 6 months

Principal Investigator

Man Fung Yuen, Prof

Investigator Role:

Principal Investigator

Investigator Affiliation:

Department of Medicine, Queen Mary Hospital/ The University of Hong Kong

Authority:

Hong Kong: Ethics Committee

Study ID:

EC 1942-02

NCT ID:

NCT00563095

Start Date:

March 2004

Completion Date:

December 2008

Related Keywords:

  • Carcinoma, Hepatocellular
  • Hepatocellular carcinoma
  • Carcinoma
  • Carcinoma, Hepatocellular

Name

Location